

share
Balicatib CAS NO 354813-19-7
Unit Price:
CAS No.:354813-19-7
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Balicatib is a potent and selective inhibitor of cathepsin K, a key enzyme involved in bone resorption. This compound is of significant interest for research into metabolic bone diseases such as osteoporosis. It serves as a critical reference standard and active pharmaceutical ingredient (API) intermediate for pharmaceutical development and advanced biochemical studies. Researchers and manufacturers in the pharmaceutical and biotechnology sectors require this high-purity compound for drug discovery and process development.
Application
- Primary pharmaceutical research into osteoporosis and other bone-related disorders.
- Use as a reference standard in analytical method development and validation (HPLC, LC-MS).
- Preclinical and clinical drug development for cathepsin K inhibition.
- Biochemical research to study the mechanism of action of cysteine protease inhibitors.
- Intermediate in the synthesis of novel therapeutic agents targeting bone metabolism.
Basic Information
| Product Name | Balicatib |
| CAS No. | 354813-19-7 |
| Molecular Formula | C₁₅H₁₅F₂N₃O₃ |
| Molecular Weight | 323.29 g/mol |
| Synonyms | AAE581; N-((1S)-2,2,2-Trifluoro-1-[4'-fluoro(1,1'-biphenyl)-4-yl]ethyl)-4-fluoro-4-methylpiperidine-1-carboxamide; (S)-N-(2,2,2-Trifluoro-1-(4'-fluoro-[1,1'-biphenyl]-4-yl)ethyl)-4-fluoro-4-methylpiperidine-1-carboxamide; Balicatib (AAE581); Cathepsin K Inhibitor AAE581 |
| EINECS | Contact for details |
Quality Control
Our Balicatib is manufactured under strict quality systems to ensure high purity and batch-to-batch consistency, suitable for research and development applications. Each batch is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to relevant ICH guidelines for stability and impurity characterization to support regulatory submissions.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Due to its hygroscopic nature, the container should be kept in a desiccated environment to prevent moisture absorption.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white powder |
| Identification (IR) | Conforms to structure |
| Identification (HPLC) | Retention time matches reference standard |
| Assay (HPLC) | ≥98.0% |
| Related Substances (HPLC) | Total impurities ≤2.0% |
| Single Unknown Impurity | ≤0.5% |
| Water Content (KF) | ≤1.0% |
| Residue on Ignition | ≤0.1% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Cilastatin Sodium CAS NO 81129-83-1


Glutathione CAS NO 70-18-8


Elamipretide CAS NO 736992-21-5


Cytisine CAS NO 485-35-8


Aviptadil CAS NO 40077-57-4


Rmc6236 CAS NO 2765081-21-6


Dl-Noradrenaline CAS NO 138-65-8


Ly 246708 Tartrate CAS NO 152854-19-8


Cibinetide CAS NO 1208243-50-8


Coluracetam CAS NO 135463-81-9


Lanreotide CAS NO 108736-35-2


Cysteamine Hydrochloride CAS NO 156-57-0


Nicotine Ditartrate CAS NO 65-31-6


Tigapotide CAS NO 848084-83-3


Linaclotide Acetate CAS NO 851199-60-5


Ziconotide Acetate CAS NO 914454-03-8


Glepaglutide CAS NO 914009-86-2


Oxyphenisatine Di(Acetate) CAS NO 115-33-3


5-[2-(Diethylammonio)Ethyl]-3-(1-Phenylpropyl)-1,2,4-Oxadiazolediylium Citrate CAS NO 132-35-4


Magnesium o-Acetylsalicylate CAS NO 132-49-0
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






